Avita Medical earnings were -$43.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest RCEL earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$7.7M, down 27.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, RCEL reported annual earnings of -$48.6M, with -21.4% growth.
On RCEL's earnings call on Aug 6, 2026, Avita Medical (NASDAQ: RCEL) reported Q2 2026 earnings per share (EPS) of -$0.25, up 34.21% year over year. Total RCEL earnings for the quarter were -$7.66 million. In the same quarter last year, Avita Medical's earnings per share (EPS) was -$0.38.
As of the last Avita Medical earnings report, Avita Medical is currently losing money. Avita Medical's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$43.08 million, a 16.46% decrease year over year.
What was RCEL's earnings growth in the past year?
As of Avita Medical's earnings date in Aug 6, 2026, Avita Medical's earnings has grown year over year. RCEL earnings in the past year totalled -$43.08 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.